VEGFA and neoplasm: Furthermore, several in vivo and in vitro studies have revealed that HDAC inhibitors, including NaB, SAHA, TSA and FK228, inhibit tumor angiogenesis via downregulation of the mRNA and protein expression of VEGF (21–24).